![]() | ||
|
Copyright 2008 MediaNews Group, Inc. and Mid-States Newspapers, Inc. All Rights Reserved Sentinel & Enterprise (Fitchburg, Massachusetts) |
|
May 15, 2008 Thursday
|
|
SECTION: LOCAL
|
|
LENGTH: 228 words
|
| HEADLINE: Quaid testifies about peril to newborn twins |
|
BYLINE: Sentinel and Enterprise
|
|
BODY:
WASHINGTON (AP) -- Actor Dennis Quaid told Congress on Wednesday of a harrowing, near-fatal drug mixup in which his newborn twins were administered 1,000 times the normal dose of a blood thinner. The actor said his family's brush with tragedy underscores the need to hold pharmaceutical companies accountable through lawsuits, a remedy that is becoming increasingly problematic for injured consumers.Some 7,000 Americans die every year from medication errors.At issue before the House Reform and Government Oversight Committee is a move by regulators at the Food and Drug Administration to step into lawsuits on the side of defendant drug companies.In court, the drug companies argue that federal regulation should pre-empt the filing of lawsuits under state law, a matter that will come before the Supreme Court later this year in a case from Vermont.The Quaid family is suing drug maker Baxter Healthcare Corp., which is seeking dismissal of the lawsuit on federal pre-emption grounds that the FDA approved the labeling.Quaid told the committee his family's life-altering story began in November 2007 when twins Thomas and Zoe, at the time 12 days old, developed a staph infection and had to be hospitalized.The children were mistakenly administered the wrong version of the drug heparin, due to two concentrations of the drug being bottled with similar labels and size.
|
|
LOAD-DATE: May 15, 2008
|
estoppel by judgment barring the relitigation of issues litigated by the same parties on a different cause of action
More Legal News